Experimental Agent Blocks Prostate Cancer In Animal Study

Courtesy ScienceDaily  Fri, 05/23/2008 - 09:30

An experimental drug has blocked the progression of prostate cancer in an animal model with an aggressive form of the disease, new research shows.

The agent, OSU-HDAC42, belongs to a new class of drugs called histone deacetylase (HDAC) inhibitors, compounds designed to reactivate genes that normally protect against cancer but are turned off by the cancer process.

The study showed that the agent kept mice with a precancerous condition from developing advanced prostate cancer.

Human testing of the compound is expected to begin early next year.

Tags:

 

Related items

Pigs Bred With Cystic Fibrosis Provide Model To Mimic Human...
Cystic fibrosis continues to be a lethal disease for humans despite the identification of the problematic gene two decades ago. Many humans born with...

Gene Therapy Prevents Blindness In An Animal Model Of...
Scientists have created an animal model suitable for testing and validating gene therapies for treatment of a common mitochondrial dysfunction that...

Height linked to risk of prostate cancer development and...
(American Association for Cancer Research) A man's height is a modest marker for risk of prostate cancer development, but is more strongly linked to...

Yerkes researchers create animal model of chronic stress
(Emory University) In an effort to better understand how chronic stress affects the human body, researchers have created an animal model that shows...

Why A Common Treatment For Prostate Cancer Ultimately Fails
Some of the drugs given to many men during their fight against prostate cancer can actually spur some cancer cells to grow, researchers have found.


 

Post new comment

The content of this field is kept private and will not be shown publicly.
science-nature.marc8.com